Trial Details
COMPLETEDBasic Information
| Clinical ID | c4306 |
|---|---|
| Identifier | NCT00727298 |
| Trial Title | Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Arthritis, Rheumatoid|Spondylitis, Ankylosing|Arthritis, Psoriatic|Psoriasis|Crohn's Disease |
| Interventions | BIOLOGICAL: Infliximab |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2006-02 |
|---|---|
| Primary Completion Date | 2011-08 |
| Completion Date | 2011-08 |